Mechano-redox control of integrin de-adhesion

  1. Freda Passam
  2. Joyce Chiu
  3. Lining Ju
  4. Aster Pijning
  5. Zeenat Jahan
  6. Ronit Mor-Cohen
  7. Adva Yeheskel
  8. Katra Kolšek
  9. Lena Thärichen
  10. Camilo Aponte-Santamaría
  11. Frauke Gräter
  12. Philip J Hogg  Is a corresponding author
  1. University of New South Wales, Australia
  2. University of Sydney, Australia
  3. Tel Aviv University, Israel
  4. Heidelberg Institute of Theoretical Studies, Germany
  5. University of Los Andes, Colombia

Abstract

How proteins harness mechanical force to control function is a significant biological question. Here we describe a human cell surface receptor that couples ligand binding and force to trigger a chemical event which controls the adhesive properties of the receptor. Our studies of the secreted platelet oxidoreductase, ERp5, have revealed that it mediates release of fibrinogen from activated platelet αIIbβ3 integrin. Protein chemical studies show that ligand binding to extended αIIbβ3 integrin renders the βI-domain Cys177-Cys184 disulfide bond cleavable by ERp5. Fluid shear and force spectroscopy assays indicate that disulfide cleavage is enhanced by mechanical force. Cell adhesion assays and molecular dynamics simulations demonstrate that cleavage of the disulfide induces long-range allosteric effects within the βI-domain, mainly affecting the metal-binding sites, that results in release of fibrinogen. This coupling of ligand binding, force and redox events to control cell adhesion may be employed to regulate other protein-protein interactions.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files.

Article and author information

Author details

  1. Freda Passam

    St George Clinical School, University of New South Wales, Kogarah, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Joyce Chiu

    Centenary Institute, University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Lining Ju

    Heart Research Institute, University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Aster Pijning

    Centenary Institute, University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Zeenat Jahan

    St George Clinical School, University of New South Wales, Kogarah, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Ronit Mor-Cohen

    Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Competing interests
    The authors declare that no competing interests exist.
  7. Adva Yeheskel

    George S Wise Faculty of Life Science, Tel Aviv University, Tel Aviv, Israel
    Competing interests
    The authors declare that no competing interests exist.
  8. Katra Kolšek

    Heidelberg Institute of Theoretical Studies, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  9. Lena Thärichen

    Heidelberg Institute of Theoretical Studies, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  10. Camilo Aponte-Santamaría

    Max Planck Tandem Group in Computational Biophysics, University of Los Andes, Bogotá, Colombia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-8427-6965
  11. Frauke Gräter

    Heidelberg Institute of Theoretical Studies, Heidelberg, Germany
    Competing interests
    The authors declare that no competing interests exist.
  12. Philip J Hogg

    Centenary Institute, University of Sydney, Sydney, Australia
    For correspondence
    phil.hogg@sydney.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6486-2863

Funding

National Health and Medical Research Council (Research Fellowship 1110219)

  • Philip J Hogg

Deutsche Forschungsgemeinschaft (Research Unit FOR 1543)

  • Katra Kolšek
  • Camilo Aponte-Santamaría
  • Frauke Gräter

National Heart Foundation of Australia (Australia Postdoctoral Fellowship 101285)

  • Lining Ju

Klaus Tschira Stiftung

  • Frauke Gräter

Diabetes Australia Research Trust (Grant G179720)

  • Lining Ju

Royal College of Pathologists of Australasia (Kanematsu/Novo Nordisk Research Award)

  • Freda Passam
  • Lining Ju

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Human subjects: All procedures involving collection of human blood from healthy volunteers were in accordance with the St George Hospital Human Ethics Committee (HREC 12/252), Human Research Ethics Committee (HREC) (Project number 2014/244) of the University of Sydney , and the Helsinki Declaration of 1983.

Copyright

© 2018, Passam et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,396
    views
  • 470
    downloads
  • 52
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Freda Passam
  2. Joyce Chiu
  3. Lining Ju
  4. Aster Pijning
  5. Zeenat Jahan
  6. Ronit Mor-Cohen
  7. Adva Yeheskel
  8. Katra Kolšek
  9. Lena Thärichen
  10. Camilo Aponte-Santamaría
  11. Frauke Gräter
  12. Philip J Hogg
(2018)
Mechano-redox control of integrin de-adhesion
eLife 7:e34843.
https://doi.org/10.7554/eLife.34843

Share this article

https://doi.org/10.7554/eLife.34843

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Jie Luo, Jeff Ranish
    Tools and Resources

    Dynamic conformational and structural changes in proteins and protein complexes play a central and ubiquitous role in the regulation of protein function, yet it is very challenging to study these changes, especially for large protein complexes, under physiological conditions. Here, we introduce a novel isobaric crosslinker, Qlinker, for studying conformational and structural changes in proteins and protein complexes using quantitative crosslinking mass spectrometry. Qlinkers are small and simple, amine-reactive molecules with an optimal extended distance of ~10 Å, which use MS2 reporter ions for relative quantification of Qlinker-modified peptides derived from different samples. We synthesized the 2-plex Q2linker and showed that the Q2linker can provide quantitative crosslinking data that pinpoints key conformational and structural changes in biosensors, binary and ternary complexes composed of the general transcription factors TBP, TFIIA, and TFIIB, and RNA polymerase II complexes.

    1. Biochemistry and Chemical Biology
    2. Stem Cells and Regenerative Medicine
    Alejandro J Brenes, Eva Griesser ... Angus I Lamond
    Research Article

    Human induced pluripotent stem cells (hiPSCs) have great potential to be used as alternatives to embryonic stem cells (hESCs) in regenerative medicine and disease modelling. In this study, we characterise the proteomes of multiple hiPSC and hESC lines derived from independent donors and find that while they express a near-identical set of proteins, they show consistent quantitative differences in the abundance of a subset of proteins. hiPSCs have increased total protein content, while maintaining a comparable cell cycle profile to hESCs, with increased abundance of cytoplasmic and mitochondrial proteins required to sustain high growth rates, including nutrient transporters and metabolic proteins. Prominent changes detected in proteins involved in mitochondrial metabolism correlated with enhanced mitochondrial potential, shown using high-resolution respirometry. hiPSCs also produced higher levels of secreted proteins, including growth factors and proteins involved in the inhibition of the immune system. The data indicate that reprogramming of fibroblasts to hiPSCs produces important differences in cytoplasmic and mitochondrial proteins compared to hESCs, with consequences affecting growth and metabolism. This study improves our understanding of the molecular differences between hiPSCs and hESCs, with implications for potential risks and benefits for their use in future disease modelling and therapeutic applications.